HIV-1 Tat Protein (47-57)
SIGMA/H0292
CAS Number: 191936-91-1
Empirical Formula (Hill Notation): C64H118N32O14
Molecular Weight: 1559.83
MDL Number: MFCD07366706
Linear Formula: C64H118N32O14
Product Type: Chemical
| biological source | synthetic |
| form | lyophilized powder |
| InChI | 1S/C64H118N32O14/c65-25-3 |
| InChI key | RAVVEEJGALCVIN-AGVBWZICSA |
| Quality Level | 200 ![]() |
| shipped in | dry ice |
| SMILES string | NCCCC[C@H](NC(=O)[C@H](CC |
| solubility | deionized water: soluble |
| storage temp. | −20°C |
| Amino Acid Sequence: | Tyr-Gly-Arg-Lys-Lys-Arg-A |
| Biochem/physiol Actions: | Synthetic peptide that includes the sequence responsible for the cellular uptake of the human immunodeficiency virus-1 Tat protein, consisting of the polycationic region 49–57. The peptide is part of the protein transduction domain (PTD) and was shown to enable the introduction of nucleic acids into cells. |
| General description: | HIV-1 trans-activator of transcription (Tat) is an 11kDa protein, which regulates HIV-1 gene expression at the level of transcription and protein synthesis. It is located in the nucleus of infected cells. HIV-1 Tat functions as a transcriptional activator for the synthesis of full-length viral RNA. It induces RNA splicing. Tat is an RNA binding protein, which particularly recognizes trans activator response element (TAR) from the HIV-1 RNA molecule. |
| Other Notes: | Lyophilized from 0.1% TFA in H2O |
| Physical form: | Lyophilized from 0.1% aqueous trifluoroacetate (TFA). |
| RIDADR | NONH for all modes of transport |
| WGK Germany | nwg |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352202 |

